执行总监

Rosemary Molinari

Rosemary Molinari, Executive Director, provides overall leadership to all functions, cohesively addressing risk management and strategic planning to support core teams throughout the study. Rosemary has 25 years of Fortrea experience with expertise in managing Phase I through IV studies from protocol development through to submissions to regulatory authorities. She has experience in both global and North American studies in the areas of Type 1 and Type 2 diabetes, CV and cardiovascular outcome studies.

您的需求——我们的解决方案。

作为I期至IV期临床试验管理、临床药理学、患者通道解决方案和其他支持服务的综合提供商，Fortrea与新兴及大型生物制药、医疗器材和诊断公司合作，推动全球医疗保健创新。